Emerging frontiers in assisted reproductive technology: Balancing innovation and ethics in AI-driven embryo selection and personalized medicine

Conflict of interest statement

The authors declare no competing interests.

Funding

The study receives no extramural funding.

Authors’ contributions

Nancy Nair contributed to the conception or design of the work, drafting of the work, approval of the final version of the manuscript, and agreed on all aspects of the work. Vaishnavi Mishra contributed to the literature review, revision of the manuscript for important intellectual content, approval of the final version of the manuscript, and agreed to all aspects of the work. Ankit Badge contributed to the literature review, revision of the manuscript for important intellectual content, approval of the final version of the manuscript, and agreed to all aspects of the work. Sahil Shendre contributed to the review and revision of the manuscript for important intellectual content.

Publisher’s Note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Mapari SA, Shrivastava D, Bedi GN, Pradeep U, Gupta A, Kasat PR, et al. Revolutionizing reproduction: The impact of robotics and artificial intelligence (AI) in assisted reproductive technology: A comprehensive review. Cureus 2024; 16(6):e63072. doi: 10.7759/cureus.63072.

[2] Glatstein I, Chavez-Badiola A, Curchoe CL. New frontiers in embryo selection. J Assist Reprod Genet 2023; 40(2):223-234.

[3] Olawade DB, Teke J, Adeleye KK, Weerasinghe K, Maidoki M, David-Olawade AC. Artificial Intelligence in in-vitro fertilization (IVF): A new era of precision and personalization in fertility treatments. J Gynecol Obstet Hum Reprod 2025; 54(3):102903.

[4] Tribulations and future opportunities for artificial intelligence in precision medicine. J Transl Med 2024; 22(1):411. doi: 10.1186/s12967-02405067-0.

[5] Sadee W, Wang D, Hartmann K, Toland AE. Pharmacogenomics: Driving personalized medicine. Pharmacol Rev 2023; 75(4):789-814.

[6] Rubin DB, van der Laan MJ. Statistical issues and limitations in personalized medicine research with clinical trials. Int J Biostat 2012; 8(1):18.

[7] Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, et al. Advancing precision medicine: A review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics 2024; 16(3):332.

[8] Díaz-Rodríguez N, Del Ser J, Coeckelbergh M, López de Prado M, Herrera-Viedma E, Herrera F. Connecting the dots in trustworthy artificial intelligence: From AI principles, ethics, and key requirements to responsible AI systems and regulation. Information Fusion 2023; 99:101896.

[9] Salih M, Austin C, Warty RR, Tiktin C, Rolnik DL, Momeni M, et al. Embryo selection through artificial intelligence versus embryologists: A systematic review. Hum Reprod Open 2023; 2023(3):hoad031.